Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus. [electronic resource]
Producer: 20180718Description: 62-72 p. digitalISSN:- 1477-0962
- Adult
- Antimalarials -- administration & dosage
- Artemisinins -- administration & dosage
- Artesunate
- Blotting, Western
- Case-Control Studies
- Dose-Response Relationship, Drug
- Enzyme-Linked Immunosorbent Assay
- Female
- Gene Expression Regulation -- drug effects
- Human Umbilical Vein Endothelial Cells
- Humans
- Interferon Type I -- metabolism
- Interferon-alpha -- administration & dosage
- Intramolecular Oxidoreductases -- drug effects
- Leukocytes, Mononuclear -- drug effects
- Lupus Erythematosus, Systemic -- drug therapy
- Macrophage Migration-Inhibitory Factors -- drug effects
- Male
- Middle Aged
- Phosphorylation
- Real-Time Polymerase Chain Reaction
- STAT1 Transcription Factor -- genetics
- Time Factors
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.